Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


5 Ann Intern Med
1 Antiviral Res
2 Arch Virol
1 BMC Pediatr
1 Epidemiol Infect
3 J Epidemiol Community Health
1 J Gen Virol
3 J Immunol
1 J Infect
6 J Virol
17 Lancet
1 Minerva Pediatr (Torino)
5 MMWR Morb Mortal Wkly Rep
8 N Engl J Med
1 Pediatrics
3 PLoS Med
45 PLoS One
7 Proc Natl Acad Sci U S A
6 Vaccine
1 Virology
1 Virus Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Intern Med

  1. CHO BH, Weinbaum C, Tsai Y, Koppaka R, et al
    Influenza Vaccine Uptake and Missed Opportunities Among the Medicare-Covered Population With High-Risk Conditions During the 2018 to 2019 Influenza Season : A Retrospective Cohort Study.
    Ann Intern Med. 2021 Nov 16. doi: 10.7326/M21-1550.
    PubMed         Abstract available

  2. MUSEY PI, Hunter BR
    Black patients with COVID-19 had increased risk for 30-d mortality, PE, and other adverse outcomes vs. White patients.
    Ann Intern Med. 2021 Nov 2. doi: 10.7326/ACPJ202111160.
    PubMed         Abstract available

  3. MAKI DG
    Recommendations were made for diagnosis and management of allergic reactions to COVID-19 vaccines.
    Ann Intern Med. 2021 Nov 2. doi: 10.7326/ACPJ202111160.
    PubMed         Abstract available

    The Novavax vaccine had 90% efficacy against COVID-19 >/=7 d after the second dose.
    Ann Intern Med. 2021 Nov 2. doi: 10.7326/ACPJ202111160.
    PubMed         Abstract available

  5. LO CKL, Chagla Z
    In patients hospitalized for COVID-19, tocilizumab reduces mortality at 28 d.
    Ann Intern Med. 2021 Nov 2. doi: 10.7326/ACPJ202111160.
    PubMed         Abstract available

    Antiviral Res

  6. VANDERLINDEN E, Marchand A, Van Berwaer R, van Dam W, et al
    A broad influenza virus inhibitor acting via IMP dehydrogenase and in synergism with ribavirin.
    Antiviral Res. 2021 Nov 15:105208. doi: 10.1016/j.antiviral.2021.105208.
    PubMed         Abstract available

    Arch Virol

  7. VIJAYAKUMAR P, Raut AA, Chingtham S, Murugkar HV, et al
    Proteomic analysis of differential expression of lung proteins in response to highly pathogenic avian influenza virus infection in chickens.
    Arch Virol. 2021 Nov 16. pii: 10.1007/s00705-021-05287.
    PubMed         Abstract available

  8. TSUNEKI-TOKUNAGA A, Kondo T, Kanai K, Itagaki A, et al
    Local spread of influenza A (H1N1) viruses without a mutation for the maximum duration of an epidemic season in Japan.
    Arch Virol. 2021 Nov 11. pii: 10.1007/s00705-021-05301.
    PubMed         Abstract available

    BMC Pediatr

  9. HOLM-JACOBSEN JN, Vonasek JH, Hagstrom S, Donneborg ML, et al
    Prolonged rectal shedding of SARS-CoV-2 in a 22-day-old-neonate: a case report.
    BMC Pediatr. 2021;21:506.
    PubMed         Abstract available


    Buyer beware: molnupiravir may damage DNA.
    BMJ. 2021;375:n2663.

  11. KLEEFSTRA S, Leistikow I
    Turning patient engagement into the "new normal".
    BMJ. 2021;375:n2695.

  12. PAN D, Sze S, Martin CA, Nazareth J, et al
    Covid-19 and ethnicity: we must seek to understand the drivers of higher transmission.
    BMJ. 2021;375:n2709.

  13. SHAH R, Absoud M
    The failure of provision for neurodiverse children during the covid-19 pandemic.
    BMJ. 2021;375:n2711.

  14. ALI R, Raleigh V, Majeed A, Khunti K, et al
    Life expectancy by ethnic group in England.
    BMJ. 2021;375:e068537.

    Overdiagnosis and overtreatment during the covid-19 pandemic.
    BMJ. 2021;375:n2688.

    Epidemiol Infect

  16. NICHOLS M, Gollarza L, Palacios A, Stapleton GS, et al
    Salmonella illness outbreaks linked to backyard poultry purchasing during the COVID-19 pandemic: United States, 2020.
    Epidemiol Infect. 2021;149:e234.
    PubMed         Abstract available

    J Epidemiol Community Health

  17. BANN D, Villadsen A, Maddock J, Hughes A, et al
    Changes in the behavioural determinants of health during the COVID-19 pandemic: gender, socioeconomic and ethnic inequalities in five British cohort studies.
    J Epidemiol Community Health. 2021;75:1136-1142.
    PubMed         Abstract available

  18. JANNOT AS, Countouris H, Van Straaten A, Burgun A, et al
    Low-income neighbourhood was a key determinant of severe COVID-19 incidence during the first wave of the epidemic in Paris.
    J Epidemiol Community Health. 2021;75:1143-1146.
    PubMed         Abstract available

  19. GRIFFITH GJ, Davey Smith G, Manley D, Howe LD, et al
    Interrogating structural inequalities in COVID-19 mortality in England and Wales.
    J Epidemiol Community Health. 2021;75:1165-1171.
    PubMed         Abstract available

    J Gen Virol

  20. ORR-BURKS N, Murray J, Todd KV, Bakre A, et al
    MicroRNAs affect GPCR and Ion channel genes needed for influenza replication.
    J Gen Virol. 2021;102.
    PubMed         Abstract available

    J Immunol

  21. BANSAL S, Perincheri S, Fleming T, Poulson C, et al
    Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines.
    J Immunol. 2021 Oct 15. pii: jimmunol.2100637. doi: 10.4049/jimmunol.2100637.
    PubMed         Abstract available

  22. PAIDI RK, Jana M, Mishra RK, Dutta D, et al
    Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.
    J Immunol. 2021 Oct 13. pii: jimmunol.2100144. doi: 10.4049/jimmunol.2100144.
    PubMed         Abstract available

  23. LIU Y, Budylowski P, Dong S, Li Z, et al
    SARS-CoV-2-Reactive Mucosal B Cells in the Upper Respiratory Tract of Uninfected Individuals.
    J Immunol. 2021;207:2581-2588.
    PubMed         Abstract available

    J Infect

  24. TILLARD C, Chazard E, Faure K, Bartolo S, et al
    Burden of influenza disease in children under 2 years of age hospitalized between 2011 and 2020 in France.
    J Infect. 2021 Nov 13. pii: S0163-4453(21)00549.
    PubMed         Abstract available

    J Virol

  25. NILSSON-PAYANT BE, Uhl S, Grimont A, Doane AS, et al
    The NF-kappaB transcriptional footprint is essential for SARS-CoV-2 replication.
    J Virol. 2021 Sep 15:JVI0125721. doi: 10.1128/JVI.01257.
    PubMed         Abstract available

  26. TOSTANOSKI LH, Gralinski LE, Martinez DR, Schaefer A, et al
    Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2.
    J Virol. 2021 Sep 15:JVI0097421. doi: 10.1128/JVI.00974.
    PubMed         Abstract available

  27. CHOI A, Koch M, Wu K, Dixon G, et al
    Serum Neutralizing Activity of mRNA-1273 Against SARS-CoV-2 Variants.
    J Virol. 2021 Sep 22:JVI0131321. doi: 10.1128/JVI.01313.
    PubMed         Abstract available

  28. QIAN Y, Lei T, Patel PS, Lee CH, et al
    Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin.
    J Virol. 2021 Sep 22:JVI0139621. doi: 10.1128/JVI.01396.
    PubMed         Abstract available

  29. CHAI H, Li X, Li M, Lv X, et al
    Emergence, Evolution, and Pathogenicity of Influenza A(H7N4) Virus in Shorebirds, China.
    J Virol. 2021 Nov 17:JVI0171721. doi: 10.1128/JVI.01717.
    PubMed         Abstract available

  30. DANIELS RS, Galiano M, Ermetal B, Kwong J, et al
    Temporal and gene reassortment analysis of influenza C outbreaks in Hong Kong SAR, China.
    J Virol. 2021 Nov 17:JVI0192821. doi: 10.1128/JVI.01928.
    PubMed         Abstract available


  31. YOUNG-WOLFF KC, Ray GT, Alexeeff SE, Adams SR, et al
    Rates of Prenatal Cannabis Use Among Pregnant Women Before and During the COVID-19 Pandemic.
    JAMA. 2021 Sep 27. pii: 2784637. doi: 10.1001/jama.2021.16328.

  32. ESTCOURT LJ, Turgeon AF, McQuilten ZK, McVerry BJ, et al
    Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
    JAMA. 2021 Oct 4. pii: 2784914. doi: 10.1001/jama.2021.18178.
    PubMed         Abstract available

  33. CONNORS JM, Brooks MM, Sciurba FC, Krishnan JA, et al
    Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial.
    JAMA. 2021 Oct 11. pii: 2785218. doi: 10.1001/jama.2021.17272.
    PubMed         Abstract available

  34. RUBIN R
    Trying to Block SARS-CoV-2 Transmission With Intranasal Vaccines.
    JAMA. 2021 Oct 14. pii: 2785303. doi: 10.1001/jama.2021.18143.

  35. KUEHN BM
    COVID-19 Precautions Help Make Music That's Beautiful and Safe.
    JAMA. 2021 Oct 14. pii: 2785304. doi: 10.1001/jama.2021.17558.

  36. WEBB SA, Higgins AM, McArthur CJ
    Glucocorticoid Dose in COVID-19: Lessons for Clinical Trials During a Pandemic.
    JAMA. 2021 Oct 21. pii: 2785531. doi: 10.1001/jama.2021.16438.

  37. FANAROFF AC, Garcia S, Giri J
    Myocardial Infarction During the COVID-19 Pandemic.
    JAMA. 2021 Oct 29. pii: 2785894. doi: 10.1001/jama.2021.19608.


  38. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic.
    Lancet. 2021 Oct 8. pii: S0140-6736(21)02143.
    PubMed         Abstract available

  39. KOLA L, Kohrt BA, Acharya B, Mutamba BB, et al
    The path to global equity in mental health care in the context of COVID-19.
    Lancet. 2021 Oct 7. pii: S0140-6736(21)02233.

  40. DE FOO C, Grepin KA, Cook AR, Hsu LY, et al
    Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore.
    Lancet. 2021 Oct 4. pii: S0140-6736(21)02186.

  41. LANE R
    Gagandeep Kang: helping to shape a healthier India.
    Lancet. 2021;398:947.

    Myanmar's democracy and health on life support.
    Lancet. 2021;397:1035.

  43. AUCOTT JN, Rebman AW
    Long-haul COVID: heed the lessons from other infection-triggered illnesses.
    Lancet. 2021;397:967-968.

  44. KATES J, Dawson L, Horn TH, Killelea A, et al
    Insurance coverage and financing landscape for HIV treatment and prevention in the USA.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00397.
    PubMed         Abstract available

  45. MAYER KH, Nelson L, Hightow-Weidman L, Mimiaga MJ, et al
    The persistent and evolving HIV epidemic in American men who have sex with men.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00321.
    PubMed         Abstract available

  46. TAQUET M, Holmes EA, Harrison PJ
    Depression and anxiety disorders during the COVID-19 pandemic: knowns and unknowns.
    Lancet. 2021 Oct 8. pii: S0140-6736(21)02221.

  47. HILLSON K, Clemens SC, Madhi SA, Voysey M, et al
    Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination.
    Lancet. 2021 Oct 21. pii: S0140-6736(21)02282.

  48. LAZARUS R, Baos S, Cappel-Porter H, Carson-Stevens A, et al
    Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02329.
    PubMed         Abstract available

  49. GRANGE Z, Buelo A, Sullivan C, Moore E, et al
    Characteristics and risk of COVID-19-related death in fully vaccinated people in Scotland.
    Lancet. 2021 Oct 28. pii: S0140-6736(21)02316.

  50. GOLD C
    Unclear conclusions on SARS-CoV-2 elimination versus mitigation.
    Lancet. 2021;398:1566.

  51. OLIU-BARTON M, Pradelski BSR, Aghion P, Artus P, et al
    Unclear conclusions on SARS-CoV-2 elimination versus mitigation - Authors' reply.
    Lancet. 2021;398:1566-1567.

  52. ALVES L
    Health experts welcome Brazil COVID-19 inquiry findings.
    Lancet. 2021;398:1674-1675.

  53. LEUNG GM
    Nowcasting towards sustainable SARS-CoV-2 endemicity.
    Lancet. 2021 Oct 27. pii: S0140-6736(21)02386.

  54. SONABEND R, Whittles LK, Imai N, Perez-Guzman PN, et al
    Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
    Lancet. 2021 Oct 27. pii: S0140-6736(21)02276.
    PubMed         Abstract available

    Minerva Pediatr (Torino)

  55. YASMIN F, Bin Zafar MD, Salman A, Farooque U, et al
    Exploring the impact of the COVID-19 pandemic on pediatric surgical services.
    Minerva Pediatr (Torino). 2021;73:460-466.
    PubMed         Abstract available

    MMWR Morb Mortal Wkly Rep

  56. WOODWORTH KR, Moulia D, Collins JP, Hadler SC, et al
    The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1579-1583.
    PubMed         Abstract available

  57. FRENCH G, Hulse M, Nguyen D, Sobotka K, et al
    Impact of Hospital Strain on Excess Deaths During the COVID-19 Pandemic - United States, July 2020-July 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1613-1616.
    PubMed         Abstract available

  58. CZEISLER ME, Barrett CE, Siegel KR, Weaver MD, et al
    Health Care Access and Use Among Adults with Diabetes During the COVID-19 Pandemic - United States, February-March 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1597-1602.
    PubMed         Abstract available

  59. NALEWAY AL, Groom HC, Crawford PM, Salas SB, et al
    Incidence of SARS-CoV-2 Infection, Emergency Department Visits, and Hospitalizations Because of COVID-19 Among Persons Aged >/=12 Years, by COVID-19 Vaccination Status - Oregon and Washington, July 4-September 25, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1608-1612.
    PubMed         Abstract available

  60. FARRELL L, Almond CR, Porterfield DS, Mobley V, et al
    Automated Digital Notification of COVID-19 Diagnoses Through Text and Email Messaging - North Carolina, December 2020-January 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1603-1607.
    PubMed         Abstract available

    N Engl J Med

  61. THOMAS SJ, Moreira ED Jr, Kitchin N, Absalon J, et al
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
    N Engl J Med. 2021 Sep 15. doi: 10.1056/NEJMoa2110345.
    PubMed         Abstract available

  62. EL SAHLY HM, Baden LR, Essink B, Doblecki-Lewis S, et al
    Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
    N Engl J Med. 2021 Sep 22. doi: 10.1056/NEJMoa2113017.
    PubMed         Abstract available

  63. MERISON T, Goldman A, Bomze D
    Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113862.

  64. O'BRIEN MP, Hou P, Weinreich DM
    Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19. Reply.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113862.

    SARS-CoV-2 Infection among Nursing Home Residents.
    N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114113.

  66. WHITE EM, Mor V
    SARS-CoV-2 Infection among Nursing Home Residents. Reply.
    N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114113.

    Rare Skin Reactions after mRNA Vaccination, Similar to Jones-Mote Basophil Responses.
    N Engl J Med. 2021;385:1720-1721.

  68. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Do We Have the Tools to End the Covid-19 Pandemic?
    N Engl J Med. 2021;385:e78.


  69. MARTIN AA, Harris CE, Ang JY
    RE: Racial and Ethnic Disparities in Multisystem Inflammatory Syndrome in Children.
    Pediatrics. 2021;148.

    PLoS Med

  70. BHANU C, Gopal DP, Walters K, Chaudhry UAR, et al
    Vaccination uptake amongst older adults from minority ethnic backgrounds: A systematic review.
    PLoS Med. 2021;18:e1003826.
    PubMed         Abstract available

  71. STOVER J, Glaubius R, Teng Y, Kelly S, et al
    Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030.
    PLoS Med. 2021;18:e1003831.
    PubMed         Abstract available

  72. MARTIN CA, Marshall C, Patel P, Goss C, et al
    SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.
    PLoS Med. 2021;18:e1003823.
    PubMed         Abstract available

    PLoS One

  73. KAFFAI M, Heiberger RH
    Modeling non-pharmaceutical interventions in the COVID-19 pandemic with survey-based simulations.
    PLoS One. 2021;16:e0259108.
    PubMed         Abstract available

  74. RAO CY, Robinson T, Huster K, Laws RL, et al
    Occupational exposures and mitigation strategies among homeless shelter workers at risk of COVID-19.
    PLoS One. 2021;16:e0253108.
    PubMed         Abstract available

  75. FRIMPONG JA, Helleringer S
    Strategies to increase downloads of COVID-19 exposure notification apps: A discrete choice experiment.
    PLoS One. 2021;16:e0258945.
    PubMed         Abstract available

  76. DOHERTY IA, Pilkington W, Brown L, Billings V, et al
    COVID-19 vaccine hesitancy in underserved communities of North Carolina.
    PLoS One. 2021;16:e0248542.
    PubMed         Abstract available

  77. MOL MBA, Strous MTA, van Osch FHM, Vogelaar FJ, et al
    Heart-rate-variability (HRV), predicts outcomes in COVID-19.
    PLoS One. 2021;16:e0258841.
    PubMed         Abstract available

  78. BERMAN L, Kavalier M, Gelana B, Tesfaw G, et al
    Utilizing the SEIPS model to guide hand hygiene interventions at a tertiary hospital in Ethiopia.
    PLoS One. 2021;16:e0258662.
    PubMed         Abstract available

  79. FILLMORE N, Bell S, Shen C, Nguyen V, et al
    Disulfiram use is associated with lower risk of COVID-19: A retrospective cohort study.
    PLoS One. 2021;16:e0259061.
    PubMed         Abstract available

  80. MULLER SA, Balmer M, Charlton W, Ewert R, et al
    Predicting the effects of COVID-19 related interventions in urban settings by combining activity-based modelling, agent-based simulation, and mobile phone data.
    PLoS One. 2021;16:e0259037.
    PubMed         Abstract available

  81. ARGOTE TIRONI P, Barham E, Zuckerman Daly S, Gerez JE, et al
    Messages that increase COVID-19 vaccine acceptance: Evidence from online experiments in six Latin American countries.
    PLoS One. 2021;16:e0259059.
    PubMed         Abstract available

  82. POUDEL AN, Zhu S, Cooper N, Roderick P, et al
    Impact of Covid-19 on health-related quality of life of patients: A structured review.
    PLoS One. 2021;16:e0259164.
    PubMed         Abstract available

  83. KABIR H, Nasrullah SM, Hasan MK, Ahmed S, et al
    Perceived e-learning stress as an independent predictor of e-learning readiness: Results from a nationwide survey in Bangladesh.
    PLoS One. 2021;16:e0259281.
    PubMed         Abstract available

  84. MONDAL MRH, Bharati S, Podder P
    CO-IRv2: Optimized InceptionResNetV2 for COVID-19 detection from chest CT images.
    PLoS One. 2021;16:e0259179.
    PubMed         Abstract available

  85. DEKEL B, Abrahams N
    'I will rather be killed by corona than by him...': Experiences of abused women seeking shelter during South Africa's COVID-19 lockdown.
    PLoS One. 2021;16:e0259275.
    PubMed         Abstract available

  86. MUGAMBE RK, Ssekamatte T, Kisaka S, Wafula ST, et al
    Extent of compliance with COVID-19 prevention and control guidelines among supermarkets in Kampala Capital City and Mukono Municipality, Uganda.
    PLoS One. 2021;16:e0258840.
    PubMed         Abstract available

  87. TEELUCK M, Samura A
    Assessing the appropriateness of the Moving Epidemic Method and WHO Average Curve Method for the syndromic surveillance of acute respiratory infection in Mauritius.
    PLoS One. 2021;16:e0252703.
    PubMed         Abstract available

  88. CARVALLO CHAIGNEAU FR, Walsh P, Lebedev M, Mutua V, et al
    A randomized controlled trial comparing non-steroidal anti-inflammatory and fusion protein inhibitors singly and in combination on the histopathology of bovine respiratory syncytial virus infection.
    PLoS One. 2021;16:e0252455.
    PubMed         Abstract available

  89. FOSCO C, Zurita F
    Assessing the short-run effects of lockdown policies on economic activity, with an application to the Santiago Metropolitan Region, Chile.
    PLoS One. 2021;16:e0252938.
    PubMed         Abstract available

  90. MOHSIN SS, Abbas Q, Chowdhary D, Khalid F, et al
    Multisystem inflammatory syndrome (MIS-C) in Pakistani children: A description of the phenotypes and comparison with historical cohorts of children with Kawasaki disease and myocarditis.
    PLoS One. 2021;16:e0253625.
    PubMed         Abstract available

  91. YOUSEFI NOORAIE R, Warren K, Juckett LA, Cao QA, et al
    Individual- and group-level network-building interventions to address social isolation and loneliness: A scoping review with implications for COVID19.
    PLoS One. 2021;16:e0253734.
    PubMed         Abstract available

  92. LEE K, Ray J, Safta C
    The predictive skill of convolutional neural networks models for disease forecasting.
    PLoS One. 2021;16:e0254319.
    PubMed         Abstract available

  93. KUNDU R, Das R, Geem ZW, Han GT, et al
    Pneumonia detection in chest X-ray images using an ensemble of deep learning models.
    PLoS One. 2021;16:e0256630.
    PubMed         Abstract available

  94. RINCON URIBE FA, Godinho RCS, Machado MAS, Oliveira KRDSG, et al
    Health knowledge, health behaviors and attitudes during pandemic emergencies: A systematic review.
    PLoS One. 2021;16:e0256731.
    PubMed         Abstract available

  95. DOSHI S, Banavar SP, Flaum E, Kulkarni S, et al
    Applying heat and humidity using stove boiled water for decontamination of N95 respirators in low resource settings.
    PLoS One. 2021;16:e0255338.
    PubMed         Abstract available

  96. LEHMANN A, Prosch H, Zehetmayer S, Gysan MR, et al
    Impact of persistent D-dimer elevation following recovery from COVID-19.
    PLoS One. 2021;16:e0258351.
    PubMed         Abstract available

  97. EXLINE MC, Stanacevic M, Bowman AS, Gouma PI, et al
    Exhaled nitric oxide detection for diagnosis of COVID-19 in critically ill patients.
    PLoS One. 2021;16:e0257644.
    PubMed         Abstract available

  98. ELLIOTT T, Yehia BR, Winegar AL, Raja JK, et al
    Analysis of COVID-19 vaccine non-intent by essential vs non-essential worker, demographic, and socioeconomic status among 101,048 US adults.
    PLoS One. 2021;16:e0258540.
    PubMed         Abstract available

  99. ZUIL M, Benitez ID, Cabo-Gambin R, Manzano Senra C, et al
    Clinical management and outcome differences between first and second waves among COVID-19 hospitalized patients: A regional prospective observational cohort.
    PLoS One. 2021;16:e0258918.
    PubMed         Abstract available

  100. WILLIAMS SN, Armitage CJ, Tampe T, Dienes KA, et al
    Public perceptions of non-adherence to pandemic protection measures by self and others: A study of COVID-19 in the United Kingdom.
    PLoS One. 2021;16:e0258781.
    PubMed         Abstract available

  101. ELARDE J, Kim JS, Kavak H, Zufle A, et al
    Change of human mobility during COVID-19: A United States case study.
    PLoS One. 2021;16:e0259031.
    PubMed         Abstract available

  102. QUINTANA-DOMEQUE C, Lee I, Zhang A, Proto E, et al
    Anxiety and depression among medical doctors in Catalonia, Italy, and the UK during the COVID-19 pandemic.
    PLoS One. 2021;16:e0259213.
    PubMed         Abstract available

  103. VASELLI NM, Hungerford D, Shenton B, Khashkhusha A, et al
    The seroprevalence of SARS-CoV-2 during the first wave in Europe 2020: A systematic review.
    PLoS One. 2021;16:e0250541.
    PubMed         Abstract available

  104. PENNEY MD, Yargic Y, Smolin L, Thommes EW, et al
    "Hot-spotting" to improve vaccine allocation by harnessing digital contact tracing technology: An application of percolation theory.
    PLoS One. 2021;16:e0256889.
    PubMed         Abstract available

  105. STOCKELER AM, Schuster P, Zimmermann M, Hanses F, et al
    Influenza vaccination coverage among emergency department personnel is associated with perception of vaccination and side effects, vaccination availability on site and the COVID-19 pandemic.
    PLoS One. 2021;16:e0260213.
    PubMed         Abstract available

  106. JINDRA C, Hainisch EK, Rummele A, Wolschek M, et al
    Influenza virus vector iNS1 expressing bovine papillomavirus 1 (BPV1) antigens efficiently induces tumour regression in equine sarcoid patients.
    PLoS One. 2021;16:e0260155.
    PubMed         Abstract available

  107. MUFLIHAH H, Florido M, Lin LCW, Xia Y, et al
    Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection.
    PLoS One. 2021;16:e0259829.
    PubMed         Abstract available

  108. PAPAZOGLOU DD, Baretella O, Feller M, Del Giovane C, et al
    Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients.
    PLoS One. 2021;16:e0260112.
    PubMed         Abstract available

  109. MIRON VD, Banica L, Sandulescu O, Paraschiv S, et al
    Clinical and molecular epidemiology of influenza viruses from Romanian patients hospitalized during the 2019/20 season.
    PLoS One. 2021;16:e0258798.
    PubMed         Abstract available

  110. LOPEZ-RUIZ VR, Huete-Alcocer N, Alfaro-Navarro JL, Nevado-Pena D, et al
    The relationship between happiness and quality of life: A model for Spanish society.
    PLoS One. 2021;16:e0259528.
    PubMed         Abstract available

  111. HYLAND P, Vallieres F, Hartman TK, McKay R, et al
    Detecting and describing stability and change in COVID-19 vaccine receptibility in the United Kingdom and Ireland.
    PLoS One. 2021;16:e0258871.
    PubMed         Abstract available

  112. LEE I, Tipoe E
    Changes in the quantity and quality of time use during the COVID-19 lockdowns in the UK: Who is the most affected?
    PLoS One. 2021;16:e0258917.
    PubMed         Abstract available

  113. PRICE BS, Khodaverdi M, Halasz A, Hendricks B, et al
    Predicting increases in COVID-19 incidence to identify locations for targeted testing in West Virginia: A machine learning enhanced approach.
    PLoS One. 2021;16:e0259538.
    PubMed         Abstract available

  114. GHAEMI ASL M, Tavakkoli HR, Rashidi MM
    Sector-by-sector analysis of dependence dynamics between global large-cap companies and infectious diseases: A time-varying copula approach in EBOV and COVID-19 episodes.
    PLoS One. 2021;16:e0259282.
    PubMed         Abstract available

  115. DUARTE F, Jimenez-Molina A
    Psychological distress during the COVID-19 epidemic in Chile: The role of economic uncertainty.
    PLoS One. 2021;16:e0251683.
    PubMed         Abstract available

  116. MEGAHED FM, Jones-Farmer LA, Zhao L, Rigdon SE, et al
    Modeling the differences in the time-series profiles of new COVID-19 daily confirmed cases in 3,108 contiguous U.S. counties: A retrospective analysis.
    PLoS One. 2021;16:e0242896.
    PubMed         Abstract available

  117. QUINCHO-LOPEZ A, Benites-Ibarra CA, Hilario-Gomez MM, Quijano-Escate R, et al
    Self-medication practices to prevent or manage COVID-19: A systematic review.
    PLoS One. 2021;16:e0259317.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  118. JO WK, Schadenhofer A, Habierski A, Kaiser FK, et al
    Reverse genetics systems for contemporary isolates of respiratory syncytial virus enable rapid evaluation of antibody escape mutants.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  119. BASHOR L, Gagne RB, Bosco-Lauth AM, Bowen RA, et al
    SARS-CoV-2 evolution in animals suggests mechanisms for rapid variant selection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  120. CHANDLER JC, Bevins SN, Ellis JW, Linder TJ, et al
    SARS-CoV-2 exposure in wild white-tailed deer (Odocoileus virginianus).
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  121. TERRIER C, Chen DL, Sutter M
    COVID-19 within families amplifies the prosociality gap between adolescents of high and low socioeconomic status.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  122. PENG Y, Wu P, Schartup AT, Zhang Y, et al
    Plastic waste release caused by COVID-19 and its fate in the global ocean.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  123. SAMET JM, Burke TA, Lakdawala SS, Lowe JJ, et al
    SARS-CoV-2 indoor air transmission is a threat that can be addressed with science.
    Proc Natl Acad Sci U S A. 2021;118.

  124. LAUGHNER JL, Neu JL, Schimel D, Wennberg PO, et al
    Societal shifts due to COVID-19 reveal large-scale complexities and feedbacks between atmospheric chemistry and climate change.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


  125. ANDRADE G
    Covid-19 vaccine hesitancy, conspiracist beliefs, paranoid ideation and perceived ethnic discrimination in a sample of University students in Venezuela.
    Vaccine. 2021 Oct 22. pii: S0264-410X(21)01371.
    PubMed         Abstract available

  126. MCLEAN HQ, Levine MZ, King JP, Flannery B, et al
    Serologic response to sequential vaccination with enhanced influenza vaccines: Open label randomized trial among adults aged 65-74 years.
    Vaccine. 2021 Nov 10. pii: S0264-410X(21)01415.
    PubMed         Abstract available

  127. SHACHOR-MEYOUHAS Y, Hussein K, Szwarcwort-Cohen M, Weissman A, et al
    Single BNT162b2 vaccine dose produces seroconversion in under 60 s cohort.
    Vaccine. 2021 Oct 23. pii: S0264-410X(21)01327.
    PubMed         Abstract available

  128. KIM D, Pekgun P, Yildirim I, Keskinocak P, et al
    Resource allocation for different types of vaccines against COVID-19: Tradeoffs and synergies between efficacy and reach.
    Vaccine. 2021 Oct 18. pii: S0264-410X(21)01346.
    PubMed         Abstract available

  129. MOGHNIEH R, Mekdashi R, El-Hassan S, Abdallah D, et al
    Immunogenicity and reactogenicity of BNT162b2 booster in BBIBP-CorV-vaccinated individuals compared with homologous BNT162b2 vaccination: Results of a pilot prospective cohort study from Lebanon.
    Vaccine. 2021 Oct 13. pii: S0264-410X(21)01314.
    PubMed         Abstract available

  130. MOTTELSON A, Vandeweerdt C, Atchapero M, Luong T, et al
    A self-administered virtual reality intervention increases COVID-19 vaccination intention.
    Vaccine. 2021 Oct 8. pii: S0264-410X(21)01311.
    PubMed         Abstract available


  131. TRIGUEIRO-LOURO J, Santos LA, Almeida F, Correia V, et al
    NS1 protein as a novel anti-influenza target: Map-and-mutate antiviral rationale reveals new putative druggable hot spots with an important role on viral replication.
    Virology. 2021;565:106-116.
    PubMed         Abstract available

    Virus Res

  132. PORTER WT, Kelley EJ, Bowers JR, Engelthaler DM, et al
    Normalization of SARS-CoV-2 viral load via RT-qPCR provides higher-resolution data for comparison across time and between patients.
    Virus Res. 2021;306:198604.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.